HER2 testing is one of the most vital diagnostics in oncology, but manual interpretation slows workflows, introduces variability, and strains limited lab resources. Pathology labs need a way to increase throughput and reproducibility, without adding staff or investing in new infrastructure.
OptraSCAN’s HER2 Pilot Placement Program is designed to let your lab evaluate digital HER2 testing in a real-world workflow. With no capital expense and simple pay per-slide pricing, you’ll see how digital technology can support greater efficiency and scalability in HER2 testing.
Up to
60%
increase in throughput with
OptraSCAN digital + algorithm solution
This is your opportunity to be among the first to validate the next-generation HER2 Scan + Analyze Quantitative Solution. Submit the form below to sign up for your slot and know more about the Pilot Program. Our representative will get in touch with you shortly. Please complete all the questions with an asterisk (*)